JLL bids C$229m for drug company Patheon
The private equity firm, formerly called Joseph Littlejohn & Levy, holds a 30% stake in the Canadian company.
The private equity firm, formerly called Joseph Littlejohn & Levy, holds a 30% stake in the Canadian company.
Copyright PEI Media
Not for publication, email or dissemination
